LY2940680,
taledegib,
LY2940680,
1258861-20-9,
Taladegib,
LY-2940680,
4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide,
UNII-QY8BWX1LJ5,
Taladegib (LY2940680),
LY 2940680,
QY8BWX1LJ5,
4-fluoro-n-methyl-n-(1-(4-(1-methyl-1h-pyrazol-5-yl)-1-phthalazinyl)-4-piperidinyl)-2-(trifluoromethyl)benzamide,
4-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide,
4-Fluoro-N-Methyl-N-{1-[4-(1-Methyl-1h-Pyrazol-5-Yl)phthalazin-1-Yl]piperidin-4-Yl}-2-(Trifluoromethyl)benzamide,
Benzamide, 4-fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl)-4-piperidinyl)-2-(trifluoromethyl)-,
Benzamide, 4-fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)-,
Taladegib [USAN:INN],
4-Fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)benzamide,
4-Fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl}-2-(trifluoromethyl)benzamide,
4-fluoro-N-methyl-N-{1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide,
Taladegib (USAN/INN),
MLS006011066,
SCHEMBL2128615,
CHEMBL2142592,
C26H24F4N6O,
GTPL10333,
KS-00000XPN,
DTXSID50154986,
EX-A156,
SZBGQDXLNMELTB-UHFFFAOYSA-N,
BCP02512,
ABP000897,
MFCD21609264,
s2157,
ZINC68247898,
AKOS026674116,
BCP9000881,
CS-0459,
DB12550,
RL01260,
SB16504,
NCGC00263170-01,
NCGC00263170-06,
AK198942,
BC638822,
HY-13242,
QC-11811,
SMR004702857,
AB0033837,
X7613,
D10671,
W-5853,
J-515412,
1KS,
LY 2940680|||4-fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)-benzamide,
D0W0SL,
cc-431,
A8651,
A11048,